Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 2
1986 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
Fukui M, Inaba M, Tsukagoshi S, Sakurai Y. Fukui M, et al. Cancer Res. 1982 Mar;42(3):1098-102. Cancer Res. 1982. PMID: 6120758
The mechanism of action of 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250), which has a broad antitumor spectrum, was examined by in vitro cell culture and enzymatic studies. ...Thus, SL-1250 might b …
The mechanism of action of 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
Inaba M, Fukui M, Yoshida N, Tsukagoshi S, Sakurai Y. Inaba M, et al. Cancer Res. 1982 Mar;42(3):1103-6. Cancer Res. 1982. PMID: 6277474
Two new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250) and 4-carbamoylimidazolium 5-olate (SM-108), were investigated for their antitumor activities against 6-mercaptopurine (6-MP)-resistant s …
Two new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250
Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
Yoshida N, Kiyohara T, Fukui M, Atsumi T, Ogino S, Inaba M, Tsukagoshi S, Sakurai Y. Yoshida N, et al. Cancer Res. 1980 Oct;40(10):3810-4. Cancer Res. 1980. PMID: 7438064
In synthetic studies on the chemical modification of the nucleoside antibiotic bredinin, two new derivatives, 5-carbamoyl-1H-imidazol-4-yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4-yl piperonylate, were found to possess …
In synthetic studies on the chemical modification of the nucleoside antibiotic bredinin, two new derivatives, 5-carbamoyl-1H-imidazol-4-yl 1 …